Antidepressants Market is expected to reach USD 37.44 Billion by 2032, and grow at a CAGR of 7.66%.

The rising prevalence of depression is attributed to increased awareness and understanding of the disorder. There has been a significant global effort to educate the public and healthcare professionals about mental health, reduce stigma, and encourage early diagnosis and treatment. Organizations such as the World Health Organization (WHO) and various national health bodies have played crucial roles in this awareness campaign. As a result, more individuals are seeking help and being diagnosed, contributing to the observed rise in reported cases of depression. This heightened awareness is leading to more people being identified with depression, who might otherwise have gone untreated. For instance, the WHO reported in September 2021 that approximately 5.0% of adults globally experienced one or more depressive episodes in their lifetime.